- Kam posunul trastuzumab deruxtecan liečbu HER2+ pozitívneho karcinómu…
Number of the records: 1  

Kam posunul trastuzumab deruxtecan liečbu HER2+ pozitívneho karcinómu prsníka?

  1. Kam posunul trastuzumab deruxtecan liečbu HER2+ pozitívneho karcinómu prsníka? = Where has trastuzumab deruxtecan moved the treatment of HER2+ positive breast cance? / Miroslava Malejčíková. Onkológia Roč. 18, č. 2 (2023), s. 132-136
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.